Abstract:Aims:This study aims to investigate and validate the potential drug target to HDAC1.Background:Human histone deacetylase 1 (HDAC1) can catalyze the deacetylation of histones belonging to the family of human histone deacetylases (HDACs). Amide hydrolase HDAC1 plays a key role in the development of many serious cancers such as prostate cancer, gastric cancer, lung cancer, esophageal cancer, colon cancer, and breast cancer. Therefore, HDAC1 inhibitors, promoting the transcription of a series of key genes such as the p53 gene and inhibiting the development of cancer through various downstream mechanisms, have great potential for the treatment of cancer.Objective:The objective of this study is to discover new skeleton HDAC1 inhibitors efficiently and conveniently with therapeutic potential for cancer.Method:Based on the crystal structure of HDAC1, through the combination of receptor-based and ligand- based virtual screening from the commercial compound library, the top-ranked compounds are selected for purchase through binding modes analysis, and their activities were verified through in vitro HDAC1 inhibitory biological experiments.Results:Based on LeDock, 5ICN showed good distinguishing ability and was used as the receptor. According to the results of the LeDock docking scoring from receptor-based virtual screening, 69 compounds with binding energy less than -7.5 kcal/mol were obtained and used for ligand-based virtual screening. A total of 21 novel compounds with high potential HDAC1 inhibitory activity were collected by combining the similarity searching (NN) and the multinomial Naive Bayes machine learning model (NB) methods. Through binding modes analysis, 10 compounds with different structures with potential HDAC1 inhibitory activity were selected and screened HDAC1 inhibitory in vitro. May267 showed moderate HDAC1 inhibitory activity, and the inhibition rate was 48% at a concentration of 20 μM.Conclusion:This study discovers novel small molecule HDAC1 inhibitors by combined receptor-based and ligand-based virtual screening strategy, which provides an efficient method for the discovery of other small molecule drugs. May267 shows moderate HDAC1 inhibitory activity, which can be further optimized as a lead compound. However, it still has the problem of poor kinase selectivity to be solved.

Small‐Molecule Fluorescent Probes for Detecting HDAC Activity

Environment-sensitive Fluorescent Inhibitors of Histone Deacetylase.

Activatable Fluorescence Probe Via Self-Immolative Intramolecular Cyclization for Histone Deacetylase Imaging in Live Cells and Tissues.

Identification of Histone Deacetylase (hdac)‐associated Proteins with DNA‐Programmed Affinity Labeling

Hyperbranched Polyester-Based Fluorescent Probe for Histone Deacetylase Via Aggregation-Induced Emission.

AIEgen Based Turn-on Fluorescent Probes of Histone Deacetylase 6 Via Restriction of Molecular Motion

Discovery of non-substrate, environmentally sensitive turn-on fluorescent probes for imaging HDAC8 in tumor cells and tissue slices

G-quadruplex-based Fluorometric Biosensor for Label-Free and Homogenous Detection of Protein Acetylation-Related Enzymes Activities.

Discovery of a fluorescent probe with HDAC6 selective inhibition.

An In-Line Capillary Electrophoresis Assay for the High-Throughput Screening of Histone Deacetylase Inhibitors.

Fluorescent reporters of the histone acetyltransferase.

A Near Infrared Fluorescent Probe for One-Step Detection of Histone Deacetylase Activity Based on an Intramolecular FRET

Gold Nanoparticle Based Fluorescence Resonance Energy Transfer Immunoassay for the Detection of the Histone Deacetylase Activity Using a Fluorescent Peptide Probe

Bioanalytical Approaches for the Detection of Protein Acetylation-Related Enzymes

Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases

Discovery of Novel Small Molecule HDAC1, 2, 3 Inhibitors -- Combined Receptor-Based and Ligand-Based Virtual Screening Strategy

Fluorescent nanosensor for probing histone acetyltransferase activity based on acetylation protection and magnetic graphitic nanocapsules

Time-Resolved Luminescence Biosensor for Continuous Activity Detection of Protein Acetylation-Related Enzymes Based on DNA-Sensitized Terbium(III) Probes

Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors

Structure-Based Inhibitor Discovery Of Class I Histone Deacetylases (Hdacs)

An Activatable and Tumor-Targeting NIR Fluorescent Probe for Imaging of Histone Deacetylase 6 in Cancer Cells and in Vivo